ライフサイエンスコーパス: immunoglobulin M

1 red among 54%, but only 3% were positive for immunoglobulin M.

2 of the CSF samples tested positive for ZIKV immunoglobulin M.

3 IL-7R and EBF but not B220, and can produce immunoglobulin M.

4 ng antibody and T-cell-independent antiviral immunoglobulin M.

5 uction of early T-cell-independent antiviral immunoglobulin M.

6 ion of Bam32 after ligation of CD40, but not immunoglobulin M.

7 ytes produce only the membrane-bound form of immunoglobulin M.

8 as used to screen serum samples for anti-CMV immunoglobulin M.

9 globulins enriched with immunoglobulin A and immunoglobulin M (250 mg/kg, intravenous).

10 Fetal immunoglobulin M against oral pathogens was detected in

11 globulins enriched with immunoglobulin A and immunoglobulin M alleviated the symptoms of sickness beh

12 ox/lox)-CD19(+/Cre) mice have an increase in immunoglobulin M and CD43 and a decrease in CD5 expressi

13 Herein we demonstrate that immunoglobulin M and complement-opsonized Brucella abort

14 ent assay for anti-HCMV immunoglobulin G and immunoglobulin M and for cIL-10 and vIL-10 levels using

15 n in 67% and complement fixation in 70%, and immunoglobulin M and G antibodies were demonstrated by e

16 immune markers of mortality, while anti-LVS immunoglobulin M and IL-1beta were associated with survi

17 r periorbital edema and Trichinella-specific immunoglobulin M and immunoglobulin G antibodies after e

18 tion, and intrathecal synthesis of borrelial immunoglobulin M and immunoglobulin G antibody in 100%,

19 Serum Borrelia immunoglobulin M and immunoglobulin G at the time of pos

20 ces of galactose expression or deposition of immunoglobulin M and immunoglobulin G were found in xeno

21 LD), an enzyme immunoassay (EIA) followed by immunoglobulin M and immunoglobulin G Western blots, per

22 it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization

23 (-) T cells, and decreases in elevated serum immunoglobulin M and inflammatory markers including inte

24 gulated the expression of cell surface CD22, immunoglobulin M and major histocompatibility complex cl

25 eroprevalence of ZIKV was 6.2% based on ZIKV immunoglobulin M and negative for dengue reactivity.

26 Immunoglobulin M and/or G borrelial serum antibodies wer

27 e confirmed by detection of measles-specific immunoglobulin M and/or RNA.

28 d human serum protein, immunoglobulin G, and immunoglobulin M), and demonstrated a high correlation w

29 and bilirubin, lower serum concentrations of immunoglobulin M, and greater occurrence of autoantibodi

30 iters of serum and cerebrospinal fluid (CSF) immunoglobulin M, and occasionally positive results of W

31 circulating transitional B cells, increased immunoglobulin M, and reduced immunoglobulin G2 levels i

32 increased proliferation in response to anti-immunoglobulin M, anti-CD40, and lipopolysaccharide.

33 on, we found that Ad is opsonized by natural immunoglobulin M antibodies and complement and that thes

34 orn to yaws-infected mothers did not produce immunoglobulin M antibodies and their organs, examined b

35 Interestingly, natural immunoglobulin M antibodies bound to virus, which trigge

36 dults were examined for immunoglobulin G and immunoglobulin M antibodies for HEV.

37 Anti-Chlamydophila immunoglobulin M antibodies in Chlamydophila PCR-positiv

38 Infection was confirmed by immunoglobulin M antibodies or ANDV RNA in blood.

39 Being positive for anticardiolipin immunoglobulin M antibodies was a risk factor for any pl

40 in G antibodies, and sometimes low levels of immunoglobulin M antibodies, to Borrelia burgdorferi (Bb

41 s kill stimulated cells in synergy with anti-immunoglobulin M antibodies.

42 donors identified with early WNV infection (immunoglobulin M antibody negative) and those with uncon

43 eness and similarly prevented donor-specific immunoglobulin M antibody production.

44 ble case required fever and a positive rapid immunoglobulin M antibody test for typhoid (TUBEX TF); a

45 Immunoglobulin M antibody testing of serum specimens and

46 One isoform, recognized by an immunoglobulin M antibody that recognizes both mammalian

47 in the United States, confirmed by high ZIKV immunoglobulin M antibody titers in serum and cerebrospi

48 An injectible, 99mTc-labeled, murine immunoglobulin M antibody to stage-specific embryonic an

49 he infection when low levels of neutralizing immunoglobulin M antibody were detected in wild-type mic

50 fected CD28(-/-) mice produced primarily the immunoglobulin M antibody, which upon passive transfer p

51 ipid rafts in response to ligation with anti-immunoglobulin M (as a surrogate for antigen) are featur

52 and 92% agreement with the anti-VCA IgG and immunoglobulin M assays.

53 In cold agglutinin disease (CAD), immunoglobulin M autoantibodies fix complement on the su

54 IL-21 integrated signals mediated by surface immunoglobulin M (B-cell receptor) and Toll-like recepto

55 previously unidentified and unique subset of immunoglobulin M(+) B cells that present with an AA4.1(-

56 vation of cells lacking ASF/SF2 through anti-immunoglobulin M-B-cell receptor cross-linking rescued v

57 h Laboratory (VDRL) test and a specific IgM (immunoglobulin M) capture enzyme-linked immunosorbent as

58 en VWF levels < 130 U/dL and both monoclonal immunoglobulin M concentration (mIgMC) and viscosity.

59 urrence with these findings, postvaccination immunoglobulin M concentrations were not significantly i

60 oint swelling and higher anti-B. burgdorferi immunoglobulin M cross-reactive responses than other str

61 -)), CD8-deficient (CD8(-/-)), and secretory immunoglobulin M-deficient (sIgM(-/-)) mice and wild-typ

62 Immunoglobulin M detection provided no advantage in sens

63 The data indicate that immunoglobulin M detection tests have limited utility fo

64 hrough dengue nonstructural protein 1 and/or immunoglobulin M detection, were included in this study

65 to acute postinfectious cold hemagglutinin (immunoglobulin M) disease.

66 an lipopolysaccharide-binding protein (LBP), immunoglobulin M endotoxin core antibodies to lipopolysa

67 n, WNV-specific B cells were not detected by immunoglobulin M enzyme-linked immunospot analysis until

68 We identified the immunoglobulin M Fc receptor (FcmuR), also known as the

69 ding alpha/beta interferon (IFN-alpha/beta), immunoglobulin M, gammadelta T cells, and complement aga

70 infection (viral nonstructural protein 1 and immunoglobulin M) has greatly simplified laboratory-base

71 the stability of the alternatively expressed immunoglobulin M heavy chain secretory mRNA is developme

72 The immunoglobulin M heavy-chain locus contains two poly(A)

73 Escherichia coli K1 bacteria, we produced 12 immunoglobulin M hybridomas secreting monoclonal antibod

74 BV infection in nine cases of X-linked hyper-immunoglobulin M (hyper-IgM) syndrome who, due to a muta

75 We sought to characterize monoclonal immunoglobulin (M-Ig) light chains before clinical prese

76 ated transgenic zebrafish in which the major immunoglobulin M (IgM(+)) B-cell subset expresses green

77 To prevent immunoglobulin M (IgM) "flare," single agent bortezomib

78 Detection of donor-reactive immunoglobulin M (IgM) AECAs did not correlate with incr

79 ntial for generating acute pathogen-specific immunoglobulin M (IgM) and early IgG, which reduced path

80 d splicing substrates derived from the mouse immunoglobulin M (IgM) and human immunodeficiency virus

81 nosorbent assays for anti-H. pylori-specific immunoglobulin M (IgM) and IgA established using bacteri

82 hose obtained by BLOTrix analysis of MarBlot immunoglobulin M (IgM) and IgG and by ViraScan analysis

83 immunosorbent assay (ELISA) that can detect immunoglobulin M (IgM) and IgG antibodies in patients wi

84 S21, stimulated the production of high-titer immunoglobulin M (IgM) and IgG antibodies.

85 for the detection of both ORO virus-specific immunoglobulin M (IgM) and IgG antibodies.

86 The GM2-KLH/QS-21 vaccine induces high immunoglobulin M (IgM) and IgG antibody responses.

87 terize the nanoscale spatial organization of immunoglobulin M (IgM) and IgG BCRs on the surfaces of r

88 gingivalis CPS developed elevated levels of immunoglobulin M (IgM) and IgG in serum that reacted wit

89 Anti-PfGPI immunoglobulin M (IgM) and IgG levels were measured in 3

90 GC-dependent immune responses, reduces total immunoglobulin M (IgM) and IgG levels, and leads to incr

91 eatures, including continuous high titers of immunoglobulin M (IgM) and IgG reactivity throughout all

92 ssociated with higher brain CFU, lower serum immunoglobulin M (IgM) and IgG responses to glucuronoxyl

93 ocococcal pulmonary infection elicited serum immunoglobulin M (IgM) and IgG to the capsular polysacch

94 Antigen-specific immunoglobulin M (IgM) and IgG were produced to almost m

95 ritoneal B1 B cells, and correction of serum immunoglobulin M (IgM) and IgG(3) levels.

96 components of humoral immunity, particularly immunoglobulin M (IgM) and IgG, have critical roles in p

97 /-) mice produced low levels of WNV-specific immunoglobulin M (IgM) and IgG, viral clearance from the

98 markedly reduced levels of specific anti-WNV immunoglobulin M (IgM) and IgG.

99 abeta(+) and gammadelta(+) T cells generated immunoglobulin M (IgM) and IgG3 B. burgdorferi-reactive

100 se sensitivity and permit the measurement of immunoglobulin M (IgM) and immunoglobulin G (IgG) classe

101 ZIKV-NS1 immunoglobulin M (IgM) and immunoglobulin G (IgG) ELISAs

102 We examined immunoglobulin M (IgM) and immunoglobulin G (IgG) serolo

103 ) enzyme-linked immunosorbent assay (ELISA), immunoglobulin M (IgM) and immunoglobulin G (IgG) Wester

104 lyzed for (1) viral DNA loads, (2) anti-B19V immunoglobulin M (IgM) and immunoglobulin G (IgG), (3) a

105 gy prior to termination showed both specific immunoglobulin M (IgM) and immunoglobulin G (IgG), where

106 a positive correlation between BA plasma CMV immunoglobulin M (IgM) and liver T-cell CMV reactivity w

107 rated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a

108 y to such xenobiotics would be predominantly immunoglobulin M (IgM) and using sera from a large cohor

109 at the majority of Lyme disease patients had immunoglobulin M (IgM) and/or IgG responses to p66 and t

110 cted donors were viremic and/or positive for immunoglobulin M (IgM) and/or immunoglobulin G.

111 We investigated the pathogenicity of immunoglobulin M (IgM) anti-GM1 antibodies in serum from

112 Quantitative measurements of immunoglobulin M (IgM) anti-hepatitis B core antibody (a

113 Binding of immunoglobulin M (IgM) antibodies from normal human seru

114 the identification of rubella virus-specific immunoglobulin M (IgM) antibodies in serum, but approxim

115 or this included elevated levels of anti-HEL immunoglobulin M (IgM) antibodies in the serum of CD5(-/

116 athies associated with persistently elevated immunoglobulin M (IgM) antibodies that react with GQ1b,

117 of persons with suspected HEV was tested for immunoglobulin M (IgM) antibodies to HEV to confirm infe

118 In mice, immunoglobulin M (IgM) antibodies to the DIII-lr epitope

119 day prior to the onset of clinical disease; immunoglobulin M (IgM) antibodies were detected at low l

120 Anti-mumps virus immunoglobulin M (IgM) antibodies were detected using a

121 In analyses for immunoglobulin M (IgM) antibodies, 14 (82%) of 17 serum

122 shown to induce the production of anti-oxLDL immunoglobulin M (IgM) antibodies, due to molecular mimi

123 Detection of CHIKV-specific immunoglobulin M (IgM) antibody becomes a sensitive test

124 Immunoglobulin M (IgM) antibody to the outbreak Lp6 stra

125 eguides for the detection of dengue-specific immunoglobulin M (IgM) antibody, and we demonstrate dete

126 ing-mouse brain WN virus antigen used in the immunoglobulin M (IgM) antibody-capture and indirect IgG

127 The use of immunoglobulin M (IgM) antibody-capture enzyme-linked im

128 The immunoglobulin M (IgM) antibody-capture enzyme-linked im

129 enzyme or crude lysates generated from anti-immunoglobulin M (IgM) antibody-treated RAMOS cells.

130 ies, but not the production of low-affinity, immunoglobulin M (IgM) antibody.

131 , we report that ST6Gal-I deficiency induces immunoglobulin M (IgM) antigen receptor endocytosis in t

132 ed by a selective pressure to retain surface immunoglobulin M (IgM) BCR despite an active class-switc

133 Between 5- and 10-fold more purified human immunoglobulin M (IgM) but not IgG was deposited onto ds

134 ptor for the crystallizable fragment (Fc) of immunoglobulin M (IgM) can function as a cell-surface re

135 We developed an immunoglobulin M (IgM) capture assay (EMIBA) measuring I

136 Focus Technologies has developed an immunoglobulin M (IgM) capture enzyme-linked immunosorbe

137 y of undetermined significance (MGUS) of the immunoglobulin M (IgM) class, which progresses to lympho

138 ls in blood, and require rapid production of immunoglobulin M (IgM) for clearance.

139 Passive transfer of normal mouse serum, immunoglobulin M (IgM) from normal mouse serum, or IgG f

140 with encephalitis had orthopoxvirus-reactive immunoglobulin M (IgM) in cerebrospinal fluid.

141 rpretation of positive cytomegalovirus (CMV) immunoglobulin M (IgM) in the first trimester of pregnan

142 Immunoglobulin M (IgM) is an ancient antibody class that

143 An immunoglobulin M (IgM) kappa paraprotein was detected in

144 significantly higher and the endotoxin core immunoglobulin M (IgM) level lower in cases, compared wi

145 ated with hu5C8 secreted adenovirus-specific immunoglobulin M (IgM) levels comparable to control anim

146 utations, severe B lymphopenia and decreased immunoglobulin M (IgM) levels were noted.

147 Interestingly, anti-Bordetella serum immunoglobulin M (IgM) levels were significantly lower i

148 WNV-specific immunoglobulin M (IgM) levels were similar to those of w

149 Immunoglobulin M (IgM) monoclonal antibodies to an epito

150 lved in the pathogenesis of premalignant non-immunoglobulin M (IgM) monoclonal gammopathy of undeterm

151 MYD88 L265P was absent in 90% of immunoglobulin M (IgM) monoclonal gammopathy of undeterm

152 Immunoglobulin M (IgM) natural antibodies bind oxidative

153 detect human parvovirus B19 (B19V)-specific immunoglobulin M (IgM) or IgG in the sera of 198 pregnan

154 AL amyloidosis associated with immunoglobulin M (IgM) paraproteinemia is rare.

155 enstrom macroglobulinemia (WM), which has an immunoglobulin M (IgM) paraproteinemia, is classified as

156 antibody library obtained from a human donor Immunoglobulin M (IgM) pool was determined to be at leas

157 % CI: 0.7-4.7%) for Epstein-Barr virus (EBV) immunoglobulin M (IgM) positivity, 94.7% (95% CI: 90.7-9

158 gh TACI and BCMA, and each ligand stimulated immunoglobulin M (IgM) production by peripheral blood B

159 Both up-regulation of CD22 expression and immunoglobulin M (IgM) production, markers of CLL differ

160 lymphoma characterized by hypersecretion of immunoglobulin M (IgM) protein and tumor infiltration in

161 ltration of the bone marrow and a monoclonal immunoglobulin M (IgM) protein.

162 Odds ratios for high immunoglobulin M (IgM) reactivity to EBV-viral capsid an

163 (>/=7 days), respiratory manifestations, an immunoglobulin M (IgM) response in peripheral blood, and

164 to become activated and produce potent acute immunoglobulin M (IgM) responses.

165 cked VN activity; moreover, purified natural immunoglobulin M (IgM) restored VN activity to antibody-

166 A positive Toxoplasma immunoglobulin M (IgM) result is often interpreted as a

167 Positive immunoglobulin M (IgM) results are not sufficient as evi

168 infections and rule out misleading positive immunoglobulin M (IgM) results in areas with various lev

169 ation, loss of STAT5 significantly decreased immunoglobulin M (IgM) secretion.

170 Anti-dengue virus (DENV) immunoglobulin M (IgM) seroconversion has been the refer

171 Usually, immunoglobulin M (IgM) serologic analysis is not suffici

172 functional consequences of a single round of immunoglobulin M (IgM) signaling.

173 The hyper immunoglobulin M (IgM) syndrome (HIGM), characterized by

174 al control over high and sustained levels of immunoglobulin M (IgM) synthesis.

175 ompared the results of a serum-based measles immunoglobulin M (IgM) test with results of tests using

176 Mumps immunoglobulin M (IgM) testing was negative and reverse-

177 Although HSV-specific immunoglobulin M (IgM) titers were comparable for both B

178 1) integrins reduced B. burgdorferi-specific immunoglobulin M (IgM) titers, enhanced pathogen burden,

179 Immunoglobulin class switching from immunoglobulin M (IgM) to IgG and IgA is central to immu

180 icient mice were unable to class switch from immunoglobulin M (IgM) to IgG virus-neutralizing antibod

181 by a switch in anti-PPS14 from predominantly immunoglobulin M (IgM) to IgG1 by day 25 following prima

182 t assay (ELISA) for the detection of chicken immunoglobulin M (IgM) to WN virus was developed, standa

183 re to oral pathogens was determined by fetal immunoglobulin M (IgM) umbilical cord seropositivity.

184 In Yaounde, Cameroon, parasite-specific immunoglobulin M (IgM) was detected in 14% of cord blood

185 globulinemia (MC), a monoclonal expansion of immunoglobulin M (IgM)(+) autoreactive B cells, and also

186 these primary immunodeficiencies have fewer immunoglobulin M (IgM)(+)IgD(+)CD27(+) B cells, a popula

187 V(+)MC(+) subjects have clonal expansions of immunoglobulin M (IgM)(+)kappa(+)IgD(low/-)CD21(low)CD27

188 Levels of total immunoglobulin G (IgG), immunoglobulin M (IgM), and IgG subtypes against the fol

189 a direct relationship between surface CD79B, immunoglobulin M (IgM), and IgM-induced signaling levels

190 transfer of normal mouse serum or polyclonal immunoglobulin M (IgM), but not IgG, into B-cell-deficie

191 kin lymphoma that features overproduction of immunoglobulin M (IgM), clearly has a familial component

192 des stercoralis was shown to be dependent on immunoglobulin M (IgM), complement activation, and granu

193 In 51p1-encoded immunoglobulin M (IgM), complementarity-determining regi

194 Plasma was analyzed for anti-HCV immunoglobulin M (IgM), cytokine/granzyme concentrations

195 enzyme-linked immunospot assay, we evaluated immunoglobulin M (IgM), IgA, and IgG antibody-secreting

196 Rotavirus-specific immunoglobulin M (IgM), IgA, and IgG ASC and memory B-ce

197 serum or plasma samples were tested for WNV immunoglobulin M (IgM), IgA, and IgG by using enzyme-lin

198 accharide (PS) vaccines induce type-specific immunoglobulin M (IgM), IgG, and IgA.

199 All animals had high prechallenge levels of immunoglobulin M (IgM), IgG, IgG1, and IgG2 serum antibo

200 ell populations and reduced antigen-specific immunoglobulin M (IgM), IgG1, and IgG3 production.

201 , as well as higher concentrations of plasma immunoglobulin M (IgM), relative to individuals with the

202 WM) is characterized by an overproduction of immunoglobulin M (IgM), which can lead to a hyperviscosi

203 Recently, immunoglobulin M (IgM)-capture enzyme immunoassays for t

204 The four rapid tests were a microplate immunoglobulin M (IgM)-enzyme-linked immunosorbent assay

205 TgE Lyn(-/-) mice had a larger immunoglobulin M (IgM)-positive B-cell population than T

206 Immunoglobulin M (IgM)-related light chain (AL) amyloido

207 on of EBV latency III LCL gene expression to immunoglobulin M (IgM)-stimulated B cells, germinal-cent

208 gnals including the cross-linking of surface immunoglobulin M (IgM).

209 expansion accompanied by a serum monoclonal immunoglobulin M (IgM).

210 parenchyma to secrete polyreactive emergency immunoglobulin M (IgM).

211 tion in bone marrow, lymph node development, immunoglobulin M (IgM)/IgG production, and humoral immun

212 Prototype immunoglobulin M (IgM)/immunoglobulin G (IgG) ELISAs wer

213 58.95; P = .001) and high levels of phase II immunoglobulin M (IgM; AHR, 6.59; 95% CI, 1.37-31.62; P

214 further into the immune response by studying immunoglobulin-M (IgM) and IgG subclass 3 (IgG3) DSA to

215 the mechanisms behind WM transformation from immunoglobulin-M (IgM) monoclonal gammopathy of undeterm

216 njugates, but the Inaba-specific antibodies (immunoglobulin M [IgM] and IgG1) were neither vibriocida

217 mice produced human monoclonal paraprotein (immunoglobulin M [IgM] and/or kappa or lambda chain) det

218 fever (Widal TO and TH, anti-serotype Typhi immunoglobulin M [IgM] dipstick, and IDeaL TUBEX).

219 resistance of monoclonal antibodies B6.1 (an immunoglobulin M [IgM]) and C3.1 (an IgG3) against exper

220 e same HA copy number), the highest primary (immunoglobulin M [IgM]) and secondary (IgG) anti-HA humo

221 CAR bacillus-specific serum immunoglobulins (immunoglobulin M [IgM], IgG1, IgG2a, IgG2b, IgG3, and Ig

222 use mice (transgenic mice that express human immunoglobulin M [IgM], IgG2, and kappa) which were immu

223 three populations: somatically hypermutated immunoglobulin M(+) (IgM(+)) and IgG(+) MBC subsets and

224 Soon after BLV injection, immunoglobulin M+ (IgM+) and CD8+ cells increased in eff

225 Serum levels of immunoglobulin M, immunoglobulin A, and immunoglobulin G

226 We tested cases' sera for measles immunoglobulin M, immunoglobulin G, avidity, and plaque

227 re stained for galactose-alpha1,3-galactose, immunoglobulin M, immunoglobulin G, complement, fibrin,

228 l enzyme-linked immunosorbent assay kits for immunoglobulin M/immunoglobulin G antibodies to herpes s

229 globulins enriched with immunoglobulin A and immunoglobulin M improve the integrity of the blood-brai

230 ction, comprising approximately 90% of serum immunoglobulin M in ATA micro kappa mice.

231 The identification of West Nile virus immunoglobulin M in cerebrospinal fluid is the recommend

232 detectable levels of immunoglobulin G and/or immunoglobulin M in human plasma samples after treatment

233 In Gp1, anti-A/B and cytotoxic anti-pig immunoglobulin-M increased steadily during the first yea

234 PF-04691502 inhibited both anti-immunoglobulin M-induced signaling and overcame stroma-i

235 Immunoglobulin M is an especially important product of t

236 CD19, along with immunoglobulin M, is down-regulated in the bone marrow u

237 s and secreting Stx1-specific Hu-MAbs (seven immunoglobulin M(kappa)() [IgM(kappa)] elements [one spe

238 8 pneumococcal capsular polysaccharide D11 [immunoglobulin M(kappa)] protects wild-type and compleme

239 h nonsense CXCR4 mutations have higher serum immunoglobulin M levels and incidence of symptomatic hyp

240 w lower bone marrow disease burden and serum immunoglobulin M levels but show an increased risk of de

241 declined from 55% to 10% (P = .0004), serum immunoglobulin M levels declined from 4,830 to 1,115 mg/

242 bone marrow (BM) disease involvement, serum immunoglobulin-M levels, and symptomatic disease requiri

243 WILDTYPE (WT)) had intermediate BM and serum immunoglobulin-M levels; those with MYD88(WT)CXCR4(WT) s

244 enes (>5% deviation from germ line), surface immunoglobulin M ligation failed to induce receptor tran

245 were immunized with melanin ghosts, and two immunoglobulin M MAbs to melanin were generated from the

246 derly individuals have a lower percentage of immunoglobulin M memory B cells than healthy young adult

247 t expression of the secretory heavy chain of immunoglobulin M (micros), is well-tolerated in HeLa cel

248 The recognition of antigen by membrane immunoglobulin M (mIgM) results in a complex series of s

249 Two clonally related immunoglobulin M monoclonal Abs (MAbs) (12A1 and 13F1) d

250 Two immunoglobulin M monoclonal antibodies, H7-7 and H7-12,

251 We evaluated 99mTc-labeled anti-CD15 immunoglobulin M monoclonal antibody (LeuTech) for diagn

252 DS Eligible patients had measurable disease (immunoglobulin M monoclonal protein > 1,000 mg/dL with >

253 ABX-CBL, an immunoglobulin M murine monoclonal antibody, recognizes

254 mpared to those for a cohort of B19-specific immunoglobulin M-negative (IgM(-)), IgG(+) remotely infe

255 lored whether the presence of lipid-specific immunoglobulin M oligoclonal bands in cerebrospinal flui

256 globulins enriched with immunoglobulin A and immunoglobulin M on blood-brain barrier integrity and su

257 d B-PLL- showed best resemblance with normal immunoglobulin M-only B-cells.

258 at IFNalpha2b does not significantly inhibit immunoglobulin M or G serologic responses to the vaccine

259 Despite the lack of BB0405-specific immunoglobulin M or immunoglobulin G antibodies during n

260 he mice were incapable of Chlamydia-specific immunoglobulin M or immunoglobulin G production.

261 ad no detectable mature T and B cells, serum immunoglobulin M, or even Thy-1(+) and B220(+) precursor

262 ld rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G.

263 globulins enriched with immunoglobulin A and immunoglobulin M (p < .01).

264 ients had significant increase in polyclonal immunoglobulin M (P = .005), indicating innate immune sy

265 rom their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to

266 urred in 62% of subjects, but only 0.3% were immunoglobulin M positive.

267 based on seroconversion for HCMV and/or HCMV immunoglobulin M-positive and low or moderate HCMV immun

268 se with HEV had evidence of recent exposure (immunoglobulin M-positive).

269 s (P < 0.05) were evident in CD4(+), CD8(+), immunoglobulin M-positive, and CD172a(+) cell fractions

270 Parvovirus B19 immunoglobulin M positivity was associated with a 71% in

271 serum samples were tested for parvovirus B19 immunoglobulin M positivity.

272 ttenuates lenalidomide-mediated increases in immunoglobulin M production by normal B cells.

273 obulin G, although they were not impaired in immunoglobulin M production relative to controls.

274 ned wave of signaling that promotes specific immunoglobulin M production.

275 >/=0.2 g/24 h), absence of intact monoclonal immunoglobulin (M protein) in the serum, and no evidence

276 (FLCs), soluble CD30 (sCD30), and monoclonal immunoglobulins (M-proteins).

277 unoglobulin G: r = 0.138, P = 0.031; anti-Vi immunoglobulin M: r = 0.197, P = 0.034).

278 Both immunoglobulin M receptor-induced Ca(2+) flux and prolif

279 globulins enriched with immunoglobulin A and immunoglobulin M, respectively (p < .01).

280 The immunoglobulin M response in previously vaccinated indiv

281 oincidently with the development of a modest immunoglobulin M response.

282 p10 were needed to generate a weak anti-p10 immunoglobulin M response.

283 erm persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-mal

284 1 to drive differentiation of splenocytes to immunoglobulin M-secreting cells.

285 versus postoutbreak sample, and near-farm by immunoglobulin M seroprevalence in a municipal populatio

286 B cells from apoptosis and increases surface immunoglobulin M (sIgM) expression on murine splenic B c

287 ates of anergy, indicated by reduced surface immunoglobulin M (sIgM) levels and signaling, consequent

288 ivation also correlated closely with surface immunoglobulin M (sIgM) signaling capacity in vitro in b

289 lls were stimulated with antibody to surface immunoglobulin M (sIgM), while in B cells from uninfecte

290 ps infection can be made by the detection of immunoglobulin M-specific antibodies to mumps virus in a

291 intracellular calcium that accompanies anti-immunoglobulin M stimulation, and this effect mediates t

292 TFE3 and TFEB in T cells resulted in a hyper-immunoglobulin M syndrome due to impaired expression of

293 l anti-HBc or anti-HBc immunoglobulin G (not immunoglobulin M) test should be used.

294 Immunoglobulin M testing was conducted on serologic samp

295 globulins enriched with immunoglobulin A and immunoglobulin M treatment, no ultrastructural evidence

296 The glycoprotein is recognized by immunoglobulin M tube precipitin (TP) antibody present i

297 Type V CPS-specific immunoglobulin M was a dominant isotype of immune respon

298 produced immunoglobulin G predominantly, but immunoglobulin M was predominant in younger children.

299 ain, immunoglobulin G, immunoglobulin A, and immunoglobulin M were measured on ICU days 1, 3, and 7.

300 in ZAP-70-positive CLL trigger secretion of immunoglobulin M, which then serves as (auto-) antigen f